3rd Dermatology Drug Development Europe Summit

Therapeutic innovation in the dermatology space is growing at an exponential rate, propelling an increase in the awareness and knowledge of inflammatory skin conditions' pathophysiology.

In turn, a plethora of treatment options for chronic, moderate to severe dermatological diseases, and conditions of high unmet need, which concerns the lives of millions of individuals across the globe. As opportunities in this evolving landscape multiply, organisations and experts are motivated to pool their expertise to accelerate the delivery of innovative therapies to market.

Following a successful launch in Europe in 2019, and a tremendous online experience in 2021, the 3rd Dermatology Drug Development Europe Summit, returns in April 2022, warmly welcoming everyone back to face-to-face gatherings.

We are the only end-to-end industry meeting committed to generating new dermatological therapeutics to market through collaboration. This year's summit delivers an unrivalled prospect to industry experts in the dermatology space. Exploring methods to tackle key challenges and reviewing opportunities in the development and delivery of pioneering dermatology medicines to market.

https://dermatology-drugdevelopment-europe.com/

5-7 April, 2022
Frankfurt, Germany

Contact:
[email protected]

Others Details

URL: Brochure: https://go.evvnt.com/983037-0?pid=6581 Speakers: Ainara Rodriguez Marco, Global Medical Director Immunology and Dermatology, Sanofi Genzyme, Alan Irvine, MD DSc, Professor, Trinity College Dublin, Thorsten Thormann, Vice President, Head of Research and Early Development, LEO Pharma, Valerie Julia, Head of Research and Early Development - Global R and D, Galderma, Volker Koscielny, Chief Medical Officer, Almirall